Stock screener


All disclosures →
EDGAR →
JNJ
Conviction 81HealthcareScan · Mon, Aug 10, 2026JNJ$261.64+0.93%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
2
Vol MA14 7.76M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +0.00%· 1 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price261.64
Change+0.93%
Gap-0.03%
Rel volume1.05×
Avg volume8.26M
Avg $ vol2.12B
SMA 20256.84
SMA 50248.34
SMA 200228.39
Price vs 50+5.35%
Price vs 200+14.56%
MA stackbullish
50/200 cross—
Supertrenddown · 267.30
RSI (14)58
MACD hist-0.58
MACD crossbear · 7d
Stoch %K / %D46 / 44
ADX (14)18
+DI / −DI31 / 21
RSI divergence—
MACD divergence—
ATR %+2.27%
ADR %2.26%
52w high267.24
52w low172.78
From 52w high-2.10%
Above 52w low+51.43%
New 52w highNo
SqueezeOff
Bollinger width8.65%
%B0.72
Donchian pos54.91%
Donchian high274.90
Donchian low245.49
AVWAP (52w high)259.39
vs AVWAP high+0.87%
AVWAP (52w low)218.27
vs AVWAP low+19.87%
OBV trendUp
Chaikin MF (20)0.02
Today vs 20d1.05×
Avg vol (14d)7.76M
Avg vol (20d)8.26M
Avg $ vol (20d)2.12B
Market cap630.53B
RS 3m (vs SPY)+10.81%
RS 6m (vs SPY)-5.09%
RS line new highNo
Trend template8/8
Technical rank70.3
1 week+2.84%
1 month+1.81%
3 months+18.22%
6 months+9.02%
1 year+52.53%
YTD+26.18%
P/E23.52
P/B7.42
P/S6.69
P/FCF32.01
EPS11.03
Div yield—
ROE31.54%
ROA13.33%
Debt/Eq0.46
Current1.09
EV/EBITDA22.32
Gross margin67.88%
Net margin28.46%
Rev growth6.05%
EPS growth90.56%
Price target281.00
Target upside7.40%
Analyst ratingBuy
Institutional85.44%
Ent. value649.45B
Revenue25.31B
Net income5.53B
Gross profit17.26B
Free cash flow19.7B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out2.41B
Employees140.8K
ListedMon, Sep 25, 1944
Free float2.41B
Float %100.0%
Short interest27.43M
Days to cover3.7d
Short volume54.5%
Squeeze score31 / 100
Next earnings—
EPS forecast—
Last EPS vs est$2.90 vs $2.84
Last surprise+2.1% beat
Setup gradeA
Conviction81 / 100
Pattern quality—
Tech rank70.3 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance272.17
Support236.50
Days since event—
Candle confirm—
News sentiment—
Financials as of Sun, Jun 28, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in JNJ · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Thomas H Tuberville senate · traded 2024-10-29 | Sell | $15K–$50K | 2024-10-29 | 2026-08-05 | |
Thomas H Tuberville senate · traded 2024-10-29 | Sell | $15K–$50K | 2024-10-29 | 2026-08-05 | |
Alan Armstrong senate · R · OK · traded 2026-03-30 | Buy | $1K–$15K | 2026-03-30 | 2026-07-21 | |
Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $15K–$50K | 2026-03-27 | 2026-07-21 | |
Thomas H. Kean house · R · NJ · traded 2026-06-29 | Sell | $1K–$15K | 2026-06-29 | 2026-07-15 | |
Thomas H. Kean house · R · NJ · traded 2026-06-02 | Sell | $1K–$15K | 2026-06-02 | 2026-07-15 | |
Lloyd Doggett house · D · TX · traded 2026-06-09 | Buy | $1K–$15K | 2026-06-09 | 2026-07-06 | |
John Boozman senate · R · AR · traded 2026-03-19 | Sell | $1K–$15K | 2026-03-19 | 2026-04-14 | |
Lloyd Doggett house · TX · traded 2025-12-09 | Buy | $1K–$15K | 2025-12-09 | 2026-01-02 | |
Jared Moskowitz house · D · FL · traded 2025-10-10 | Sell | $1K–$15K | 2025-10-10 | 2025-11-22 |
Insider activity
SEC Form 4 transactions in JNJ · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Exercise | 9.34K | $1.2M | 2026-08-06 | 2026-08-07 |
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Sell | 6.57K | $1.7M | 2026-08-06 | 2026-08-07 |
Forminard Elizabeth EVP, Chief Legal Officer · Employee Stock Options (Right to Buy) · 2026-08-06 | Exercise | 9.34K | — | 2026-08-06 | 2026-08-07 |
Forminard Elizabeth EVP, Chief Legal Officer · Common Stock · 2026-08-06 | Sell | 9.34K | $2.4M | 2026-08-06 | 2026-08-07 |
Duato Joaquin CEO and Chairman of the Board · Common Stock · 2026-08-05 | Sell | 41.96K | $11M | 2026-08-05 | 2026-08-07 |
Duato Joaquin CEO and Chairman of the Board · Common Stock · 2026-08-05 | Sell | 6.52K | $1.7M | 2026-08-05 | 2026-08-07 |
REED JOHN C EVP, Innovative Medicine, R&D · Common Stock · 2026-05-01 | Exercise | 25.25K | $0 | 2026-05-01 | 2026-05-04 |
REED JOHN C EVP, Innovative Medicine, R&D · Common Stock · 2026-05-01 | Tax | 11K | $2.5M | 2026-05-01 | 2026-05-04 |
REED JOHN C EVP, Innovative Medicine, R&D · Restricted Share Units · 2026-05-01 | Exercise | 25.25K | $0 | 2026-05-01 | 2026-05-04 |
Doudna Jennifer A Director · Deferred Share Units · 2026-04-23 | Grant | 975 | $0 | 2026-04-23 | 2026-04-27 |
SEC filings
EDGAR filings in JNJ · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.